Bio-Rad Laboratories Inc (BIO)
Current ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 3,030,300 | 3,055,620 | 3,056,250 | 3,060,940 | 3,048,330 | 3,146,770 | 3,138,870 | 3,277,250 | 3,157,980 | 3,140,160 | 3,249,700 | 3,303,420 | 1,989,090 | 2,466,290 | 2,289,090 | 2,175,320 | 2,139,840 | 2,323,860 | 2,132,580 | 2,082,590 |
| Total current liabilities | US$ in thousands | 467,800 | 497,943 | 486,961 | 466,154 | 522,799 | 558,176 | 581,982 | 589,623 | 568,708 | 570,677 | 613,714 | 648,331 | 680,938 | 649,916 | 587,052 | 609,892 | 631,536 | 986,657 | 926,895 | 869,254 |
| Current ratio | 6.48 | 6.14 | 6.28 | 6.57 | 5.83 | 5.64 | 5.39 | 5.56 | 5.55 | 5.50 | 5.30 | 5.10 | 2.92 | 3.79 | 3.90 | 3.57 | 3.39 | 2.36 | 2.30 | 2.40 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $3,030,300K ÷ $467,800K
= 6.48
The current ratio of Bio-Rad Laboratories Inc has shown a consistent and strong upward trend over the past few years, indicating the company's improving liquidity position. The ratio increased from 2.40 as of March 31, 2020, to 6.48 as of December 31, 2024. This implies that the company's current assets are more than sufficient to cover its current liabilities, with a heightened level of liquidity as the ratio exceeds 1.
The current ratio surpassed 3 starting from December 31, 2020, suggesting that the company has more than $3 in current assets available to cover each $1 of current liabilities during this period. Further improvements were observed throughout the subsequent quarters, with the ratio reaching a peak of 6.57 as of March 31, 2024. This indicates a strong ability to meet its short-term obligations using its current assets.
The consistently high current ratio above 5 in the recent quarters up to December 31, 2024, indicates Bio-Rad Laboratories Inc's robust liquidity position and potential to comfortably cover its short-term liabilities. This trend suggests that the company may have ample resources to fund its operations, repay debts, and take advantage of potential investment opportunities without experiencing liquidity issues.
Peer comparison
Dec 31, 2024